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a b s t r a c t
Herpes simplex virus (HSV) undergoes a lytic infection in epithelial cells and a latent infection in
neuronal cells, and epigenetic mechanisms play a major role in the differential gene expression under
the two conditions. HSV viron DNA is not associated with histones but is rapidly loaded with
heterochromatin upon entry into the cell. Viral proteins promote reversal of the epigenetic silencing
in epithelial cells while the viral latency-associated transcript promotes additional heterochromatin in
neuronal cells. The cellular sensors that initiate the chromatinization of foreign DNA have not been fully
deﬁned. IFI16 and cGAS are both essential for innate sensing of HSV DNA, and new evidence shows how
they work together to initiate innate signaling. IFI16 also plays a role in the heterochromatinization of
HSV DNA, and this review will examine how IFI16 integrates epigenetic regulation and innate sensing of
foreign viral DNA to show how these two responses are related.
& 2015 Elsevier Inc. All rights reserved.
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Introduction
When foreign DNA is introduced into mammalian cells, host cell
responses recognize it as a potential “danger” and initiate a series of
responses that attempt to control its expression and minimize its
damage of the cell, including epigenetic silencing of the DNA to
reduce its expression, induction of DNA damage responses, induction
of innate responses, and recruitment of nuclear domain 10 (ND10) or
PML body components that reduce its expression. The mechanism(s)
by which foreign DNA is recognized and how it is distinguished from
“self” DNA are not known, and the relationships between these
responses to foreign DNA have not been deﬁned. Herpes simplex
virus (HSV) DNA evokes the same foreign DNA responses in that HSV
DNA is not associated with histones in virions but becomes rapidly
associated with chromatin upon entry into host cells, DNA damage
response proteins and ND10 proteins localize near HSV genomes,
and innate responses are induced in response to HSV DNA. However,
little has been known until recently about the cellular sensors that
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recognize HSV DNA and initiate innate responses and chromatiniza-
tion. Epigenetic mechanisms play a major role in the HSV gene exp-
ression during lytic infection of epithelial cells and latent infection of
sensory neurons. Recent studies have shown a potential link between
the innate responses to HSV and epigenetic regulation. Therefore, in
this review I will summarize the epigenetic mechanisms regulating
HSV gene expression and discuss the relationships between foreign
DNA sensing, epigenetic regulation of that DNA, and innate immune
responses. I will also examine how the cellular interferon-inducible
protein 16 (IFI16) plays a role in sensing of herpesviral DNA and in
integrating the induction of innate responses and epigenetic silencing
of the viral DNA.
Epigenetic regulation of herpes simplex virus lytic and latent
infection
HSV undergoes a lytic infection at the initial mucosal sites of in-
fection followed by spread to sensory neurons where it establishes
a latent infection (Roizman et al., 2013). Lytic infection involves the
expression of more than 80 viral genes while latent infection involves
the abundant expression of only the latency-associated transcript
(LAT) and miRNAs. The basis for the differential expression of HSV
genes during lytic infection of epithelial cells versus the expression
of only the LAT and miRNAs during latent infection has been an
important unanswered question. It has been increasingly recognized
that epigenetic mechanisms are central in regulation of eukaryotic
gene expression (Gardner et al., 2011), and these regulatory mechan-
isms also apply to HSV gene expression (Knipe and Cliffe, 2008; Knipe
et al., 2013).
Herpesviral DNA in the virion is not associated with histones, but
instead the negative charges are apparently neutralized by the poly-
amine spermine. Upon entry into the host cell nucleus of dividing
cells, HSV DNA is rapidly associated with histones (Cliffe and Knipe,
2008; Oh and Fraser, 2008), and heterochromatin modiﬁcations are
rapidly put onto the chromatin by 1–2 hpi (Liang et al., 2009; Raja, Lee,
and Knipe, manuscript in preparation). The HSV VP16 virion protein
assembles into a transactivator complex with the host cellular proteins
host cell factor 1 (HCF-1) and octamer binding factor 1 (Oct-1), and
Oct-1 and VP16 bind to sequences in the viral immediate-early
promoters, bringing the activator complex to the promoter, which
activates transcription of the immediate-early genes (Kristie, 2015;
Roizman and Zhou, 2015). HCF-1 recruits (1) the LSD1 histone
demethylase to demethylate H3K9me2 and H3K9me, (2) the JMJD2
demethylases to demethylate H3K9me3, and (3) the H3K4 methyl-
transferases to put on this euchromatin modiﬁcation. Thus, VP16 is
required for euchromatin modiﬁcations as well as reduced histone
loading on viral IE promoters (Herrera and Triezenberg, 2004). IE
genes are then expressed, including infected cell protein 0 (ICP0). ICP0
promotes histone removal and acetylation of histones on E and L
genes (Cliffe and Knipe, 2008), thereby allowing their transcription.
ICP0 disrupts the CoRest-HDAC1 complex (Gu et al., 2005) and recruits
the CLOCK histone acetyltransferase to the viral genome (Kalamvoki
and Roizman, 2010). The mechanisms by which ICP0 affects histone
methylation have not been deﬁned yet.
In contrast, during latent infection of sensory neurons, the viral
lytic genes are associated with heterochromatin (Wang et al., 2005),
primarily facultative heterochromatin (Cliffe et al., 2009; Kwiatkowski
et al., 2009), and only the LAT promoter and enhancer are associated
with euchromatin (Kubat et al., 2004a, 2004b). In neurons, HSV DNA
takes several days to become associated with histones (Cliffe et al.,
2013;Wang et al., 2005), a much longer time than in epithelial cells or
ﬁbroblasts, likely because the pool of histones is smaller in the non-
dividing neurons. From days 7–14 postinfection, histones accumulate
on the viral lytic genes and heterochromatin modiﬁcations are put on
the histones (Cliffe et al., 2013; Wang et al., 2005). Viral lytic gene
expression is very inefﬁcient because HCF-1 is in the cytoplasm of
sensory neurons (Kristie et al., 1999), and VP16 may also not localize
into the nucleus of the neurons. A neuron-speciﬁc promoter/enhancer
drives the expression of LAT (Zwaagstra et al., 1990) and the precursor
of a series of miRNAs (Kramer et al., 2011), some of which inhibit ICP4
and ICP0 expression (Umbach et al., 2008). LAT expression reduces
lytic gene expression in the neurons (Garber et al., 1997); furthermore,
LAT expression increases H3K9me2, H3K9me3, and H3K27me3
modiﬁcations on viral chromatin (Cliffe et al., 2009; Wang et al.,
2005). One study reported that LAT decreased H3K27me3 modiﬁca-
tion (Kwiatkowski et al., 2009), but in this study the levels of
H3K27me3 reported on cellular genes were different for the wild-
type samples versus the LAT promoter mutant samples. In total, the
literature supports the concept that LAT reduces lytic gene expression
during acute infection (Garber et al., 1997) and latent infection (Chen
et al., 1997) of sensory neurons, promotes heterochromatin on viral
lytic genes in sensory neurons (Cliffe et al., 2009; Wang et al., 2005),
and reduces acute infection death of neurons and increases neuronal
survival (Nicoll et al., 2012; Thompson and Sawtell, 2001). Thus, our
current working model is that HSV gene products regulate the
epigenetic modiﬁcations on the HSV genome (Fig. 1), with VP16
and ICP0 promoting euchromatin during lytic infection and LAT
promoting heterochromatin during latent infection. Many important
questions on the mechanisms of epigenetic regulation of HSV gene
expression remain as exciting areas for future study.
Attempts to cure individuals of latent viruses such as HIV have
focused on activating the virus from latency by epigenetic drugs
and then treatment with antiviral drugs (Shirakawa et al., 2013).
Reactivation of HSV from latent infection in the peripheral nervous
system and potentially in the central nervous system has the
potential for harm to the individual; therefore, the concept of lock-
ing in HSV latency with epigenetic drugs has been raised (Liang
et al., 2009). Recent studies have shown that rabbits, guinea pigs,
and mice treated with an epigenetic drug that inhibits the LSD1
histone demethylase show reduced reactivation and increased
levels of heterochromatin in vivo (Hill et al., 2014). If safe epi-
genetic drugs can be discovered that block HSV at this very early
stage of reactivation, they could have great therapeutic potential.
Sensing of foreign DNA
Mammalian cells have a number of receptors at various sites
within the cell that detect different kinds of foreign nucleic acids
and initiate innate immune responses (Iwasaki and Medzhitov,
2013). These include Toll-like receptors (TLRs) in endosomes, RIG-
like receptors in the cytosol, and DNA sensors in the cytosol and
nucleus. Organisms have also evolved mechanisms to detect foreign
DNA and degrade it or restrict its expression. Bacteria have modi-
ﬁcation-restriction systems to detect foreign DNA and cleave it
(Youell and Firman, 2012) as well as CRISPR-CAS systems to cleave
and delete sequences from the foreign DNA (Sander and Joung,
2014; Kennedy and Cullen, 2015). Mammalian cells assemble
chromatin on transfected DNA and silence its expression within a
few days (Cereghini and Yaniv, 1984). Similarly, as discussed above,
viral DNA genomes, such as those of the herpesviruses, are rapidly
associated with histones upon infection of cells, but viruses encode
proteins that combat the epigenetic silencing of their ge-
nome (Knipe et al., 2013).
Sensing of HSV DNA, innate responses, and epigenetic
regulation of foreign DNA
What are the sensors that detect the foreign DNA and initiate the
loading of heterochromatin on that DNA to silence it? The ﬁrst evi-
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dence for DNA sensors came from studies looking at the induction of
innate responses by detection of foreign DNA. There are a number of
DNA sensors that have been reported to detect viral DNA, and these
have been reviewed in a number of excellent reviews (Orzalli and
Knipe, 2014; Paludan and Bowie, 2013; Dempsey and Bowie, 2015),
to which the reader is referred for more details about these sensors.
The goal of this mini-review is to discuss the relationship between
DNA sensing, innate immune responses, and epigenetic regulation.
DNA sensing in general leads to activation of cytokine expression
through the STING-IRF-3/NF-κB pathway. Induction of the antiviral
type I IFN response is regulated by a cellular signaling cascade
that results in the activation of IFN regulatory factor-3 (IRF-3) and
nuclear factor–kappa B (NF-κB) transcription factors. A critical com-
ponent of this signaling cascade is stimulator of IFN genes (STING)
(Ishikawa et al., 2009), an endoplasmic reticulum–localized, trans-
membrane protein that bridges DNA-sensing mechanisms to down-
stream signaling events. Upon microbial DNA stimulation, STING
re-localizes to distinct intracellular foci (Saitoh et al., 2009) and
promotes TANK-binding kinase 1 (TBK1)-dependent phosphoryla-
tion of IRF-3 by a direct interaction with both proteins (Tanaka and
Chen, 2012). Phosphorylated IRF-3 dimerizes, translocates to the
nucleus, and binds to IFN-stimulated regulatory elements (ISREs) in
the promoters of IRF-3-responsive genes, including type I IFNs. IFN
is subsequently secreted from cells and can act in an autocrine or
paracrine fashion to upregulate IFN-stimulated genes (ISGs) via the
type I IFN receptor and a JAK-STAT signaling cascade (reviewed in
Stark and Darnell, 2012). A subset of ISGs can also be induced
independently of IFN, but IFN signiﬁcantly ampliﬁes this induction
(Wathelet et al., 1992).
A number of foreign DNA sensors have been reported that are
located within the cell at various sites within different cells. (1) TLR9,
located in endosomes of plasmacytoid dendritic cells, is activated by
nonmethylated CpG DNA, and TLR9 / mice are more susceptible to
HSV infection. (2) The DNA-dependent activator of interferon (DAI),
located in the cytosol, is required for IFN response to HSV-1 as
shown by siRNA depletion (Takaoka et al., 2007) but not in knockout
cells (Ishii and Akira, 2006). (3) RNA polymerase III (Ablasser et al.,
2009; Chiu et al., 2009) was reported to be required for sensing of
HSV-1 DNA (Chiu et al., 2009), but others have not seen a require-
ment (Melchjorsen et al., 2010; Monroe et al., 2014; Unterholzner
et al., 2010). (4) Absent in Melanoma 2 or AIM2 (Fernandes-Alnemri
et al., 2009; Hornung et al., 2009) is the prototypic member of
the PYHIN family of proteins, named because of their pyrin protein–
protein interaction/signaling domain and HIN (hematopoietic IFN
inducible nuclear antigen) DNA binding domain. AIM2 is involved
in the sensing of vaccinia virus and murine cytomegalovirus DNA
but not HSV DNA (Hornung et al., 2009; Rathinam et al., 2010) to
activate inﬂammasomes. (5) Interferon-inducible protein 16 or IFI16
(Unterholzner et al., 2010) is, like AIM2, a member of the PYHIN
family of proteins because it has a pyrin domain and two HIN do-
mains. IFI16 was identiﬁed originally as a cytoplasmic DNA-binding
protein and innate sensor (Unterholzner et al., 2010), but IFI16 can
be nuclear or cytoplasmic depending on the cell type (Choubey et al.,
2008). Nuclear localization of IFI16 is now known to be regulated
by acetylation (Li et al., 2012). IFI16 is capable of binding DNA
directly through sequence-independent contacts with the sugar
phosphate backbone (Jin et al., 2012), providing a biochemical basis
for DNA sensing. IFI16 is required for both activation of inﬂamma-
somes (Johnson et al., 2013; Kerur et al., 2011) and induction of IFN-
β in HSV-infected cells (Li et al., 2012; Orzalli et al., 2012). (6) Cyclic
guanosine monophosphate-adenosine monophosphate synthase or
cGAS is required for IRF-3 activation in response to transfected DNA
and HSV-1 infection (Sun et al., 2013; Wu et al., 2013). Because IFI16
and cGAS are the most extensively studied and best documented
sensors of HSV DNA in infected cells, most of the rest of my
discussion will focus on these two DNA sensors.
HSV infection induces innate responses by a number of mechan-
isms (Roizman et al., 2013). Among these, DNA-sensing plays a role
in type I interferon responses to HSV infection. UV-inactivated HSV
and HSV recombinants that do not express viral proteins induce
interferon-β in human ﬁbroblasts, but expression of viral proteins or
just ICP0 prevented induction of IFN-β (Eidson et al., 2002; Mossman
et al., 2001; Preston et al., 2001). Consistent with this, infection of
human ﬁbroblasts with the HSV-1 d109 recombinant virus that exp-
resses no viral proteins in normal cells leads to IFI16-dependent IFN-β
induction, and IFN-β induction is dependent on viral DNA entry into
the nucleus (Li et al., 2012; Orzalli et al., 2012). IFI16 must have a
functional nuclear localization signal and be localized into the nucleus
to sense HSV-1 DNA and induce IFN-β expression (Li et al., 2012).
These results are consistent with a model in which HSV DNA is rele-
ased from the capsid into the nucleus, and nuclear IFI16 binds to the
viral DNA (Fig. 2). Interestingly, as an exception to this, in human
macrophages HSV capsid proteins are ubiquitinated in the cytoplasm
and the capsid is degraded by the proteasome, but IFI16 is cytoplas-
mic in these cells and required for IFN-β induction (Horan et al.,
2013).
Fig. 1. Model for epigenetic regulation of the lytic versus latent infection decision by HSV. (A). Following infection of epithelial cells, the capsid is transported to the nuclear
pore where the viral DNA is released into the nucleus where it rapidly circularizes and becomes associated with histones bearing heterochromatin marks. VP16 from the
virion tegument forms a complex with HCF-1 and Oct1 that binds to viral IE promoters and HCF-1 recruits histone modiﬁcation enzymes and chromatin remodeling
complexes that decrease histone association with viral IE genes and increase euchromatin marks on the remaining associated histones. ICP0 is expressed as an IE protein and
it promotes similar processes on the rest of the genome. (B). Following infection of neuronal cells, the capsid is also transported to the nuclear pore where the viral DNA is
released into the nucleus where it rapidly circularizes and becomes associated with histones. VP16 cannot be transported into the neuronal nucleus, and HCF-1 is not
localized in the nucleus so viral IE genes are not transcribed efﬁciently. Instead, the latency-associated transcript is expressed and it promotes the association of facultative
heterochromatin marks on the viral chromatin (Copyright, Lynne Chang, Priya Raja, and David Knipe).
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Following binding to HSV DNA in the nucleus, IFI16 is proposed
to undergo a conformational change that allows oligomerization
as shown by intranuclear ﬁlaments or aggregates (Li et al., 2013;
Orzalli et al., 2013). The formation of higher-order complexes of
these signaling molecules is consistent with the “supramolecular
organizing centers” or SMOCs that are assembled with other innate
signaling molecules (Kagan et al., 2014). This initiates a signal that
activates STING in the cytoplasm, which activates TBK-1 phosphor-
ylation, phosphorylation and dimerization of IRF-3, and IRF-3
localization into the nucleus to bind to the IFN-β gene promoter
and activate its transcription (Orzalli et al., 2012) (Fig. 2). The nature
of the signal that moves from the nucleus to the cytoplasm to
connect IFI16 and STING is not known. In some studies, IFI16 does
not move detectably from the nucleus (Li et al., 2013, 2012; Orzalli
et al., 2012) while in others IFI16 is reported to move to the
cytoplasm and co-localize with inﬂammasome structures (Johnson
et al., 2013; Kerur et al., 2011). Therefore, the mechanism by which
IFI16 signals to STING remains a mystery. IFI16 may also play a
direct transcriptional role in innate immune induction in that it
promotes IFN-α reporter gene expression, increases RNA polymer-
ase II loading on the IFN-α gene promoter, and can bind to the IFN-
α promoter sequences (Thompson et al., 2014), although the
speciﬁcity of the in vitro binding remains to be demonstrated.
Sensing of HSV DNA and epigenetic silencing
Three of the components of the ND10 bodies, PML, hDaxx, and
Sp1, which are localized near incoming HSV genomes early during
infection, have been shown to restrict viral IE gene expression (Boutell
and Everett, 2013). Although the PML-containing ND10 structures or
bodies have been described variously as localizing “near” the viral
genomes (Maul et al., 1996) or “at the site of viral DNA” (Maul, 1998),
there no evidence that PML or other ND10 proteins associate directly
with viral DNA. Furthermore, the mechanisms of this viral restriction
have not been deﬁned. IFI16 acts as a restriction factor for HSV-1 and
HCMV replication in human embryonic lung ﬁbroblasts (Gariano
et al., 2012). The mouse homolog of IFI16 has not been deﬁned
because mice contain ten PYHIN genes while humans encode four,
but the closest functional homolog appears to be p204, and depletion
of p204 in the mouse cornea increased HSV-1 replication (Conrady
et al., 2012).
We found that depletion of IFI16 in HFF cells resulted in increased
replication and IE gene expression by an ICP0- mutant virus and that
ectopic expression of IFI16 in U2OS cells resulted in decreased IE gene
expression (Orzalli et al., 2013). Depletion of IFI16 resulted in dec-
reased H3K9me3 modiﬁcation and increased H3K4me3 modiﬁcation
on the ICP4 gene promoter, consistent with the increased ICP4 exp-
ression. The restriction effect of IFI16 was also observed on transfected
plasmids; therefore, the results were consistent with IFI16 recruiting
histone modiﬁcation enzymes that place H3K9 heterochromatin
marks on foreign DNA introduced into the cell in an unchromatinized
form. These results were recently conﬁrmed by studies in which the
IFI16 gene was deleted in U2OS cells, and the IFI16 knockout cells
showed enhanced expression of HSV IE genes, reduced heterochro-
matin, and increased euchromatin and RNA polymerase II loading on
IE genes in wildtype virus-infected cells (Johnson et al., 2014).
How does IFI16 distinguish between viral and host DNA in the
infected cell nucleus? We initially hypothesized that the IFI16 speci-
ﬁcity for viral DNA in the nucleus could involve IFI16 recognizing the
Fig. 2. Model of nuclear HSV-1 DNA sensing, innate signaling, and epigenetic regulation by IFI16 and inhibition by ICP0. HSV capsids in the cytoplasm trafﬁc to nuclear pores
where viral DNA is released into the nucleus. The viral DNA rapidly circularizes, and nuclear IFI16 binds to the viral DNA and multimerizes, initiating a nuclear-to-cytoplasmic
signaling cascade that activates IRF-3, which dimerizes and translocates to the nucleus. Immediate-early expression of ICP0 promotes degradation of IFI16 to inhibit
subsequent IRF-3 signaling and IFN-β expression. The multimerized IFI16 on the viral DNA also recruits histone modiﬁcation complexes that add H3K9me3 modiﬁcations to
the viral chromatin, resulting in epigenetic silencing of the viral genes. (Copyright, Megan Orzalli and David Knipe).
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underchromatinized viral DNA to initiate innate responses (Orzalli
et al., 2012). Consistent with this, we observed that IFI16 restric-
ted expression of the SV40 large T antigen when expressed from
a transfected plasmid but did not restrict T antigen expression in
SV40 virus-infected cells (Orzalli et al., 2013). Because SV40 DNA is
assembled in a mini-chromosome in the virion, this may make it
resistant to IFI16-mediated silencing. A biochemical explanation for
this speciﬁcity of IFI16 was provided by a recent paper which showed
that IFI16 binds cooperatively to double-stranded DNA that is 33
base pairs or longer and does not bind efﬁciently to DNA the size
of the linker DNA between nucleosomes or at a transcription bubble
(Morrone et al., 2014). Those authors also speculated that IFI16
would not bind efﬁciently to cellular DNA that is assembled in
nucleosomes.
Viral evasion of IFI16
The herpesviruses have been shown to evade the effects of
IFI16 by two mechanisms. First, ICP0 promotes the degradation of
IFI16 in HFF cells in a RING domain- and proteasome-dependent
manner (Johnson et al., 2013; Orzalli et al., 2012). Although one
study reported that ICP0 was not necessary or sufﬁcient for IFI16
degradation (Cuchet-Lourenco et al., 2013), most of the experi-
ments in this study used tumor cells where IFI16 is often not
functional and not activated by binding to HSV DNA (Li et al., 2012;
Orzalli et al., 2013). Further studies in our lab have shown that
IFI16 has a short half-life, and HSV infection can lead to both ICP0-
dependent and ICP0-independent loss of IFI16, the latter likely
involving vhs-dependent degradation of IFI16 mRNA (Orzalli,
Broekema, and Knipe, manuscript in preparation). Second, HCMV
pUL83 binds to the pyrin domain of IFI16 and prevents its multi-
merization and initiation of the IRF-3 signaling pathway (Li et al.,
2013). Therefore, both viruses target IFI16 to remove it or block its
signaling, supporting the importance of IFI16 in initiating innate
and epigenetic responses to herpesviral infection.
cGAS
In 2013, the Chen laboratory reported the discovery of the cGAS
enzyme, whose catalytic activity is activated upon binding to DNA
to synthesize cyclic guanosine monophosphate-adenosine mono-
phosphate (cGAMP) (Sun et al., 2013; Wu et al., 2013). cGAMP binds
to STING and activates the IRF-3 signaling pathway. This novel
sensor and signaling mechanism is required for HSV-1 activation of
IRF-3 dimerization (Wu et al., 2013). Cells from cGAS / mice show
reduced antiviral responses, and the cGAS / mice are more
susceptible to DNA virus infection (Li et al., 2013). These results
showed that cGAS is required for IRF-3 signaling and IFN-β induc-
tion in HSV-1 infected cells and mice. Surprisingly, Schoggins et al.
(2014) showed that cGAS / mice are also more susceptible to
RNA virus infection, indicating that cGAS activity may be pan-
antiviral (Schoggins et al., 2014). Schoggins et al. (2014) also obser-
ved a reduction in the basal levels of IFN-β and several ISGs in
cGAS-deﬁcient bone marrow-derived macrophages, implicating
cGAS in the basal homeostasis of innate signaling (Schoggins
et al., 2014). cGAMP can also spread to neighboring cells via gap
junctions to activate STING (Ablasser et al., 2013). Many proposed
DNA sensors, including IFI16, are IFN inducible; therefore, cGAS
depletion could indirectly affect the ability of additional DNA
sensors to induce antiviral cytokine production. No microbial gene
products that speciﬁcally inhibit the activity of cGAS have been
documented in publications, but we have recently identiﬁed an
HSV gene product that appears to be required for wildtype HSV
inhibition of cGAS activity (Broekema and Knipe, manuscript in
preparation).
cGAS and IFI16
In combination, these results have raised the question of how
the cytosolic cGAS and the nuclear IFI16 DNA sensors are both
required for IRF-3 signaling and interferon-β induction in HSV-
infected cells. Our own results have shown that both IFI16 and cGAS
are required for IFN-β induction by HSV-1 infection in HFFs (Orzalli
et al., 2015). However, cGAS plays a unique role in human HFF cells
in that it shows low levels of cGAMP production in HSV-infected
cells. Instead, it localizes partially in the nucleus, interacts with
IFI16, and stabilizes IFI16 against proteasomal degradation. There-
fore, cGAS may have different activities in different cell types and
under different conditions.
Role of IFI16 and cGAS in sensing DNA of other viruses
Similar to the situation with HSV, both cGAS and IFI16 have been
reported to be required for IRF-3 signaling in HIV-infected cells.
Detection of HIV reverse transcriptase products required cGAS for
IRF-3 dimerization (Gao et al., 2013). In another study, IFI16 was
found to sense HIV DNA and to restrict HIV-1 gene expression and
replication (Jakobsen et al., 2013). Induction of pyroptosis in quies-
cent CD4þ T cells requires IFI16 (Monroe et al., 2014). Therefore,
there is evidence that cGAS and IFI16 are both involved in innate
responses to and epigenetic silencing of HIV infection, and further
studies are needed to deﬁne the precise role of each in the various
cell types that HIV infects.
Normal roles of IFI16 in human cells
IFI16 has been implicated in innate responses to and restric-
tion of microbial DNA, but what physiological roles does IFI16 play
in cells not exposed to microbes? IFI16 has also been implicated in
cell senescence and cell growth control. IFI16 levels increase in
aging cells (Xin et al., 2004; Angelova and Knipe, unpublished),
and this has been implicated in the aging process. Furthermore,
IFI16 is often not expressed or defective in cancer cells (Li et al.,
2012; Orzalli et al., 2013, 2012; Xin et al., 2003). When introduced
into tumor cells, IFI16 inhibits cell growth (Xin et al., 2003; Tarnita,
Orzalli and Knipe, unpublished results), consistent with a role in
controlling normal cell growth. It will be interesting to see how
the functional mechanisms of these IFI16 activities compare with
the IFI16 mechanisms that function during innate sensing and
epigenetic silencing of foreign DNA and to see whether they are
related or distinct functions of IFI16.
Conclusion
Host cell mechanisms attempt to silence HSV DNA through
epigenetic mechanisms, but HSV and other viruses ﬁght back. In
epithelial cells the HSV VP16 virion protein promotes euchromatin
and reduced histone loading on viral immediate-early genes to
allow their transcription, and the immediate-early ICP0 protein
then promotes euchromatin and reduced histone loading on viral
early and late genes to along their expression. In neurons, LAT
promotes epigenetic silencing of viral lytic genes. As a result, viral
gene products drive the epigenetic landscape on the viral genome
during both lytic and latent infection. However, little has been
known about the host receptor that “senses” the foreign viral DNA
and promotes heterochromatin assembly on the viral genome. The
nuclear IFI16 protein is required for the major part of the IRF-3
signaling in response to HSV infection in the absence of viral
protein expression, identifying it as a potential sensor of HSV DNA.
A major remaining question is how innate signaling pathways
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connect the nuclear IFI16 with the cytoplasmic STING. IFI16 also
promotes the attachment of heterochromatic histone H3 K9 tri-
methylation marks to viral chromatin and the resulting epigenetic
silencing of the viral lytic genes. A second major question is the
mechanism(s) by which IFI16 recruits the histone modiﬁcation
enzymes to the viral chromatin for this process. It is interesting to
note that while IFI16 is hypothesized to bind to unchromatinized
viral DNA to initiate innate signaling, it promotes the chromatini-
zation of the viral DNA, so the innate signaling would be down-
regulated. Perhaps this provides a mechanism for controlling the
levels of innate responses, and an extrapolation of this is that
genetic defects in the epigenetic silencing mechanisms could lead
to uncontrolled inﬂammation. In addition to IFI16, cGAS has also
been shown to play a role in sensing of HSV DNA, and it has been
puzzling how the cytoplasmic cGAS and the nuclear IFI16 could
both be required for sensing of HSV DNA. Recent results have
shown that in human ﬁbroblasts, cGAS is partially localized to the
nucleus, interacts with IFI16, and stabilizes the IFI16 protein. A
third major question is why cGAS shows low levels of enzymatic
activity in HSV-infected cells and how viral gene products might
inhibit its activity. In conclusion, sensing of nuclear HSV DNA plays
an important role in the host innate response to viral infection and
in epigenetic regulation of viral gene expression, and there are
many exciting avenues of research that remain to be explored to
fully understand this critical area of interaction of herpesviruses
with the host cell.
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